戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tary iron supplementation is associated with increased appetite.
2 FTD and those with SD and are not limited to increased appetite.
3  and 18.1%), dry mouth (12.8% and 8.0%), and increased appetite (10.9% and 12.3%).
4 d weight loss (WL) is usually accompanied by increased appetite, a response that seems to be absent w
5  humans, acute sleep loss is associated with increased appetite and insulin insensitivity, while chro
6 gulation (hot flashes), glucose intolerance, increased appetite and reduced metabolic rate.
7  there were low levels of leptin, leading to increased appetite and suppressed fertility.
8 n to obese ewes thereby predisposing them to increased appetite and weight gain in later life.
9 pocampus and hippocampal lesions may lead to increased appetite and weight gain.
10 MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active
11 g, the experiences of out-of-control eating, increased appetite, and increased fat storage arouse gre
12 tly more weight gain and cases of dry mouth, increased appetite, and somnolence were reported with ol
13 ng treatment with olanzapine were dry mouth, increased appetite, and somnolence.
14 tness ratings of depressed participants with increased appetites, and its functional connectivity to
15 insular ingestive cortex was associated with increased appetite (bootstrap r = -0.14; 95% CI, -0.24 t
16 y, self-reproach, disturbed sleep, agitation/increased appetite, concentration/decision making, and t
17 hose on deflazacort than prednisolone, while increased appetite, cushingoid features, gastrointestina
18 tic measures to diminish the consequences of increased appetite during depressive episodes with atypi
19  favouring neurobehavioural outcomes such as increased appetite, enhanced sensitivity to food stimuli
20 ontrast, depressed participants experiencing increased appetite exhibited marked immunometabolic dysr
21  reward regions, depressed participants with increased appetites exhibited greater hemodynamic activi
22                                              Increased appetite, fatigue, drowsiness, dizziness, and
23 n the mediobasal hypothalamus (MBH) regulate increased appetite following cannabis vapor inhalation.
24 B) and 5-HT(2A) receptors, may contribute to increased appetite in rats presented with highly palatab
25  cannabinoid receptor-dependent hyperphagia (increased appetite) in fasting animals by reducing hypot
26 ness, aphthous ulcer, arthralgia, arthritis, increased appetite, increased weight, restlessness, tend
27 itability, Mood Swings, Overwhelm, Lethargy, Increased Appetite, Joint and Muscle Pain, and Breast Te
28 ts of the brain--including the hypothalamus--increased appetite, lean and fat body mass, linear growt
29 er compared with lower compensation reported increased appetite ratings and beliefs that healthy beha
30 have lower fasting plasma ghrelin levels but increased appetite, suggesting greater responses to endo
31                           Mothers exhibit an increased appetite to cope with the energetic demands of
32 included somnolence, dry mouth, weight gain, increased appetite, tremor, and slurred speech.
33 nthesis of tachykinins could not account for increased appetite, we hypothesized that increased salt
34 pring of obese sheep fed similarly exhibited increased appetite, weight gain and obesity in response
35 zapine treatment were somnolence, dry mouth, increased appetite, weight gain, akathisia, and high ala
36                   Weight gain, insomnia, and increased appetite were the most common adverse events w
37 isorder: some depressed individuals manifest increased appetite, while others lose their appetite.